464 related articles for article (PubMed ID: 36899898)
1. The Neuroprotective Activities of the Novel Multi-Target Iron-Chelators in Models of Alzheimer's Disease, Amyotrophic Lateral Sclerosis and Aging.
Kupershmidt L; Youdim MBH
Cells; 2023 Feb; 12(5):. PubMed ID: 36899898
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective and neuritogenic activities of novel multimodal iron-chelating drugs in motor-neuron-like NSC-34 cells and transgenic mouse model of amyotrophic lateral sclerosis.
Kupershmidt L; Weinreb O; Amit T; Mandel S; Carri MT; Youdim MB
FASEB J; 2009 Nov; 23(11):3766-79. PubMed ID: 19638399
[TBL] [Abstract][Full Text] [Related]
3. The novel multi-target iron chelating-radical scavenging compound M30 possesses beneficial effects on major hallmarks of Alzheimer's disease.
Kupershmidt L; Amit T; Bar-Am O; Youdim MB; Weinreb O
Antioxid Redox Signal; 2012 Sep; 17(6):860-77. PubMed ID: 22360429
[TBL] [Abstract][Full Text] [Related]
4. A Novel Iron Chelator-Radical Scavenger Ameliorates Motor Dysfunction and Improves Life Span and Mitochondrial Biogenesis in SOD1
Golko-Perez S; Amit T; Bar-Am O; Youdim MB; Weinreb O
Neurotox Res; 2017 Feb; 31(2):230-244. PubMed ID: 27826939
[TBL] [Abstract][Full Text] [Related]
5. Additive Neuroprotective Effects of the Multifunctional Iron Chelator M30 with Enriched Diet in a Mouse Model of Amyotrophic Lateral Sclerosis.
Golko-Perez S; Mandel S; Amit T; Kupershmidt L; Youdim MB; Weinreb O
Neurotox Res; 2016 Feb; 29(2):208-17. PubMed ID: 26581376
[TBL] [Abstract][Full Text] [Related]
6. Neurorescue activity, APP regulation and amyloid-beta peptide reduction by novel multi-functional brain permeable iron- chelating- antioxidants, M-30 and green tea polyphenol, EGCG.
Avramovich-Tirosh Y; Reznichenko L; Mit T; Zheng H; Fridkin M; Weinreb O; Mandel S; Youdim MB
Curr Alzheimer Res; 2007 Sep; 4(4):403-11. PubMed ID: 17908043
[TBL] [Abstract][Full Text] [Related]
7. Conservative iron chelation for neurodegenerative diseases such as Parkinson's disease and amyotrophic lateral sclerosis.
Devos D; Cabantchik ZI; Moreau C; Danel V; Mahoney-Sanchez L; Bouchaoui H; Gouel F; Rolland AS; Duce JA; Devedjian JC;
J Neural Transm (Vienna); 2020 Feb; 127(2):189-203. PubMed ID: 31912279
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective and neurorestorative activities of a novel iron chelator-brain selective monoamine oxidase-A/monoamine oxidase-B inhibitor in animal models of Parkinson's disease and aging.
Bar-Am O; Amit T; Kupershmidt L; Aluf Y; Mechlovich D; Kabha H; Danovitch L; Zurawski VR; Youdim MB; Weinreb O
Neurobiol Aging; 2015 Mar; 36(3):1529-42. PubMed ID: 25499799
[TBL] [Abstract][Full Text] [Related]
9. Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinson's disease and other neurodegenerative diseases.
Youdim MB; Fridkin M; Zheng H
J Neural Transm (Vienna); 2004 Oct; 111(10-11):1455-71. PubMed ID: 15480846
[TBL] [Abstract][Full Text] [Related]
10. Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases: in vitro studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition.
Zheng H; Gal S; Weiner LM; Bar-Am O; Warshawsky A; Fridkin M; Youdim MB
J Neurochem; 2005 Oct; 95(1):68-78. PubMed ID: 16181413
[TBL] [Abstract][Full Text] [Related]
11. Targeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelators.
Weinreb O; Mandel S; Youdim MBH; Amit T
Free Radic Biol Med; 2013 Sep; 62():52-64. PubMed ID: 23376471
[TBL] [Abstract][Full Text] [Related]
12. The novel multi-target iron chelator, M30 modulates HIF-1α-related glycolytic genes and insulin signaling pathway in the frontal cortex of APP/PS1 Alzheimer's disease mice.
Mechlovich D; Amit T; Bar-Am O; Mandel S; Youdim MB; Weinreb O
Curr Alzheimer Res; 2014 Feb; 11(2):119-27. PubMed ID: 24359498
[TBL] [Abstract][Full Text] [Related]
13. The path from anti Parkinson drug selegiline and rasagiline to multifunctional neuroprotective anti Alzheimer drugs ladostigil and m30.
Youdim MB
Curr Alzheimer Res; 2006 Dec; 3(5):541-50. PubMed ID: 17168653
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of hypoxia-inducible factor (HIF)-1α and HIF-target genes in cortical neurons by the novel multifunctional iron chelator anti-Alzheimer drug, M30.
Avramovich-Tirosh Y; Bar-Am O; Amit T; Youdim MB; Weinreb O
Curr Alzheimer Res; 2010 Jun; 7(4):300-6. PubMed ID: 20043814
[TBL] [Abstract][Full Text] [Related]
15. From anti-Parkinson's drug rasagiline to novel multitarget iron chelators with acetylcholinesterase and monoamine oxidase inhibitory and neuroprotective properties for Alzheimer's disease.
Zheng H; Amit T; Bar-Am O; Fridkin M; Youdim MB; Mandel SA
J Alzheimers Dis; 2012; 30(1):1-16. PubMed ID: 22387411
[TBL] [Abstract][Full Text] [Related]
16. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases.
Youdim MB; Fridkin M; Zheng H
Mech Ageing Dev; 2005 Feb; 126(2):317-26. PubMed ID: 15621213
[TBL] [Abstract][Full Text] [Related]
17. Multi-target iron-chelators improve memory loss in a rat model of sporadic Alzheimer's disease.
Salkovic-Petrisic M; Knezovic A; Osmanovic-Barilar J; Smailovic U; Trkulja V; Riederer P; Amit T; Mandel S; Youdim MB
Life Sci; 2015 Sep; 136():108-19. PubMed ID: 26159898
[TBL] [Abstract][Full Text] [Related]
18. Prevention of motor neuron degeneration by novel iron chelators in SOD1(G93A) transgenic mice of amyotrophic lateral sclerosis.
Wang Q; Zhang X; Chen S; Zhang X; Zhang S; Youdium M; Le W
Neurodegener Dis; 2011; 8(5):310-21. PubMed ID: 21346313
[TBL] [Abstract][Full Text] [Related]
19. Beneficial Effects of Multitarget Iron Chelator on Central Nervous System and Gastrocnemius Muscle in SOD1(G93A) Transgenic ALS Mice.
Golko-Perez S; Amit T; Youdim MB; Weinreb O
J Mol Neurosci; 2016 Aug; 59(4):504-10. PubMed ID: 27173029
[TBL] [Abstract][Full Text] [Related]
20. Novel molecular targets of the neuroprotective/neurorescue multimodal iron chelating drug M30 in the mouse brain.
Kupershmidt L; Weinreb O; Amit T; Mandel S; Bar-Am O; Youdim MB
Neuroscience; 2011 Aug; 189():345-58. PubMed ID: 21570450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]